Valuation: BOIRON

Market Cap 331M 371M 303M 276M 518M 35.08B 530M 3.63B 1.45B 18.57B 1.39B 1.36B 58.81B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 283M 317M 259M 236M 443M 30B 453M 3.1B 1.24B 15.88B 1.19B 1.17B 50.3B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
12.84%
Yield 2024
4.48%
Yield 2025 4.46%
1 day+3.67%
1 week+5.61%
Current month+5.61%
1 month+3.95%
3 months-28.18%
6 months-27.12%
Current year-34.82%
1 week 18.5
Extreme 18.5
19.75
1 month 16.9
Extreme 16.9
19.75
Current year 16.9
Extreme 16.9
30.95
1 year 16.9
Extreme 16.9
32.25
3 years 16.9
Extreme 16.9
43.96
5 years 16.9
Extreme 16.9
56.5
10 years 16.9
Extreme 16.9
92.7
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Date Insider Type Main position Quantity % Market Cap. Importance
10/29/23 Sell

Director

198,664 1.1323%
10/29/23 Sell

Director

462,964 2.6387%
10/29/23 Sell

Director

4,748 0.0271%
Change 5-day change 1-year change 3-year change Capi.($)
+3.67%+5.61%-29.21%-51.35% 371M
+0.61%+10.07%+56.36%+149.73% 1,263B
+3.81%+1.95%+47.88%+82.58% 665B
+3.09%+3.09%+36.56%+108.48% 521B
-0.37%-1.72%+48.92%+66.48% 387B
+3.93%+6.69%+79.30%+45.44% 371B
-0.36%+1.27%+31.90%+59.05% 310B
+0.11%+7.59%+12.79%+36.65% 293B
+3.73%+5.90%+61.27%+77.31% 259B
+4.19%+9.60%+41.85%+113.85% 216B
Average +1.77%+5.33%+38.76%+68.82% 428.58B
Weighted average by Cap. +1.33%+5.96%+48.76%+97.26%

Financials

2024 2025
Net sales 488M 547M 447M 406M 764M 51.71B 781M 5.34B 2.14B 27.37B 2.05B 2.01B 86.7B 501M 562M 460M 418M 785M 53.14B 803M 5.49B 2.2B 28.13B 2.11B 2.07B 89.11B
Net income 11.34M 12.72M 10.4M 9.45M 17.76M 1.2B 18.17M 124M 49.81M 636M 47.75M 46.73M 2.02B 32.64M 36.63M 29.94M 27.2M 51.14M 3.46B 52.31M 358M 143M 1.83B 137M 135M 5.8B
Net Debt -49.74M -55.82M -45.61M -41.45M -77.93M -5.27B -79.71M -545M -219M -2.79B -210M -205M -8.84B -47.86M -53.7M -43.89M -39.88M -74.98M -5.08B -76.69M -525M -210M -2.69B -202M -197M -8.51B
Projected Income Statement - Annual - BOIRON
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,623
Date Price Change Volume
26-11-05 €19.75 +3.67% 1,361
26-11-04 €19.05 +1.33% 4,740
26-11-03 €18.80 -1.05% 1,679
26-11-02 €19.00 +1.60% 3,777
26-10-30 €18.70 0.00% 1,878

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - BOIRON